Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

RVTY PEER ANALYSIS

Revvity Inc. — metric-by-metric comparison with peers and the industry median

RVTYRevvity Inc.

🇺🇸 USA · US · Healthcare · Diagnostics & Research

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Diagnostics & Research

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
RVTYIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
RVTY+8.9%ERF+13.7%SHL-14.9%
Year-to-Date (YTD)
RVTY+13.2%ERF+8.7%SHL-1.5%
1-Year
Split-adjusted
RVTY+13.8%CRL+48.6%MEDP+71.3%QGEN-14.2%GH+228.9%LH+11.2%
Year-to-Date (YTD)
RVTY+16.0%CRL+14.6%MEDP-2.7%QGEN-9.3%GH+59.5%LH+13.7%

Key Metric Comparison

P/E

Lower is better
RVTY52.02ERF27.13SHL20.04Median 30.04

ROE

Higher is better
RVTY3.3%ERF10.7%SHL6.4%Median 6.4%

Net Margin

Higher is better
RVTY8.3%ERF6.5%SHL5.2%Median 6.7%

Revenue Growth

Higher is better
RVTY4.8%ERF5.0%SHL11.4%Median 9.1%

P/E

Lower is better
RVTY52.02CRL—MEDP34.37QGEN20.12GH—LH24.99Median 30.04

ROE

Higher is better
RVTY3.3%CRL-6.0%MEDP77.3%QGEN11.9%GH—LH11.1%Median 6.4%

Net Margin

Higher is better
RVTY8.3%CRL-4.6%MEDP17.2%QGEN19.2%GH-40.1%LH6.7%Median 6.7%

Revenue Growth

Higher is better
RVTY4.8%CRL0.1%MEDP24.2%QGEN4.8%GH39.6%LH7.3%Median 9.1%

All Metrics

Valuation
MetricRVTYERFSHLInd. Median
P/E52.0227.1320.04●30.04
P/B1.753.641.26●3.40
EV/EBITDA19.4412.109.80●20.77
P/S4.321.771.04●4.26
Financial Health
MetricRVTYERFSHLInd. Median
Current Ratio1.72●1.091.011.87
Debt/Equity46.6%●153.3%85.8%49.3%
NetDebt/EBITDA3.223.20●3.781.92
Profitability
MetricRVTYERFSHLInd. Median
Net Margin8.3%●6.5%5.2%6.7%
ROE3.3%10.7%●6.4%6.4%
ROA2.0%4.3%●3.3%3.3%
EBITDA Margin26.6%●19.9%17.3%18.8%
Growth + Dividend
MetricRVTYERFSHLInd. Median
Rev. Growth4.8%5.0%11.4%●9.1%
NI Growth-22.4%16.9%●-1.1%12.4%
Div. Yield0.3%1.0%5.2%●0.8%
Payout13.4%23.2%96.9%23.2%
Valuation
MetricRVTYCRLMEDPQGENGHLHInd. Median
P/E52.02—34.3720.12●—24.9930.04
P/B1.753.8126.442.43-118.11●2.703.40
EV/EBITDA19.4448.3825.4911.69●—14.4420.77
P/S4.322.785.913.8519.801.66●4.26
Financial Health
MetricRVTYCRLMEDPQGENGHLHInd. Median
Current Ratio1.721.360.853.214.68●1.731.87
Debt/Equity46.6%103.9%20.4%49.4%-941.4%●83.0%49.3%
NetDebt/EBITDA3.229.86-0.881.29-1.54●3.031.92
Profitability
MetricRVTYCRLMEDPQGENGHLHInd. Median
Net Margin8.3%-4.6%17.2%19.2%●-40.1%6.7%6.7%
ROE3.3%-6.0%77.3%●11.9%—11.1%6.4%
ROA2.0%-2.4%22.9%●7.1%-26.6%5.1%3.3%
EBITDA Margin26.6%7.2%22.4%37.1%●-36.2%14.6%18.8%
Growth + Dividend
MetricRVTYCRLMEDPQGENGHLHInd. Median
Rev. Growth4.8%0.1%24.2%4.8%39.6%●7.3%9.1%
NI Growth-22.4%—10.6%329.3%●—28.8%12.4%
Div. Yield0.3%——0.7%—1.0%●0.8%
Payout13.4%——13.5%—25.5%23.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on RVTY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.